NCT06541834View on ClinicalTrials.gov

Predicting the Risk of Diabetic Neurodegenerative Disorders by Artificial Intelligence Tools Based on Retinal Imaging

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

August 30, 2026

Conditions
Diabete MellitusCognitive Impairment
Interventions
DEVICE

Retinal imaging

Data of retinal imaging were acquired using Spectralis (Heidelberg, Germany) and California (Optos, UK).

Trial Locations (1)

20138

RECRUITING

Ospedale San Raffaele, Milan

All Listed Sponsors
collaborator

Riccardo Sacconi

UNKNOWN

collaborator

Ilaria Zucchiatti

UNKNOWN

lead

Ospedale San Raffaele

OTHER